Ascent Industries Co. (ACNT)
ACNT trades on Nasdaq in Industrials, Major Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$13.54
-0.07% on the day
Market cap
$122.0M
Micro cap
Revenue · 2025
$74.9M
-7.2% on 2024
Net income · 2025
$867K
1.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ACNT on Nasdaq |
| Sector | Industrials |
| Industry | Major Chemicals |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000095953 |
| SEC industry code | Chemicals & Allied Products |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $74.9M |
| Net income | $867K |
| Operating income | -$7.0M |
| Net margin | 1.2% |
| Operating margin | -9.4% |
| Revenue growth | -7.2% |
| Cash | $57.6M |
| Total assets | $111.9M |
| P/E (computed) | 140.7× |
| P/S (computed) | 1.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3 | S-3 | 2026-03-31 |
| Latest annual report | 10-K | 2026-03-03 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report | 8-K | 2026-08-26 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Major Chemicals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SAFX | XCF Global Inc. | $0.2939 | -5.32% | $122.1M |
| AMTX | Aemetis Inc. (DE) | $1.56 | -2.50% | $112.6M |
| CDXS | Codexis Inc. | $1.32 | -6.38% | $144.5M |
| LODE | Comstock Inc. | $2.12 | -0.47% | $161.1M |
| ARQ | Arq Inc. | $1.97 | +0.51% | $86.0M |
| FSI | Flexible Solutions International Inc. Common Stock (CDA) | $6.08 | -0.49% | $77.7M |
| LNZA | LanzaTech Global Inc. | $5.48 | -10.16% | $71.7M |
| LTBR | Lightbridge Corporation | $5.64 | -1.57% | $211.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier